As cited by the research report titled ‘Aquaculture Healthcare Market Size By Product, By Species (Fish {Freshwater Species [Tilapia, Carp], Marine Species [Sea Bass, Sea Bream, Turbot], Diadromous Species [Salmon, Trout]}, Crustaceans {Prawns, Shrimps}), By Infections (Bacterial Infections, Viral Infections, Parasitic Infections, Fungal Infections), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Distributors, Online Stores, Retail/Aqua Stores), Regional Outlook, Price Trends, Application Potential, Competitive Market Share & Forecast, 2020 – 2026’, available with Market Study Report, global aquaculture healthcare market is projected to expand significantly over 2021-2026.
 

Growing demand for fish protein among the consumers, rising incidence of diseases & parasites in farmed fish, and increasing research & development by major companies to bring forth innovative solutions are spurring the global aquaculture healthcare market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2525385/
 

For the record, aquaculture is the farming of aquatic organisms that include fish, molluscs, crustaceans, and aquatic plants. Aquaculture healthcare covers maintenance of health of these aquatic organisms, declaring them fit for consumption.
 

As cited in the report, factors like dislike of farmed fish due to associated health concerns, dearth of knowledge regarding diseases in aquatic animals, and concerns over rising antibiotic resistance due to excessive use are likely to restrain the market progression over the forthcoming period.
 

Based on product type, global aquaculture healthcare industry is segmented into drug, vaccines, and medicated feed additives. Among these, vaccines segment is anticipated to expand at 6.4% CAGR over the forecast duration, as vaccination of fishes is vital for prevention from infectious diseases.
 

Speaking of species, the marketplace is divided into fish (marine, freshwater, diadromous species), and crustaceans. Among these, crustaceans segment is likely to witness 6.5% CAGR over the analysis period, due to growing consumption of shrimps and prawns.
 

Considering infection types, the industry space is categorized into bacterial infections, parasitic infections, viral infections, and fungal infections. Among these, fungal infection segment amassed USD 19.9 million in 2019. Fungi has the ability to exploit
any failures in the breeding environment and can affect fishes at any stage of their development.

On the basis of route of administration, the business space is fragmented into oral, topical, and injectable. Among these, injectables segment accounted for 55% market share in 2019 as the vaccine injection enables direct delivery of antigen into the body cavity or the muscle, allowing more direct stimulation of immune response.
 

Moving on to distribution channel, the market is classified into distributors, retail/aqua stores, online stores, and others. Among these, online stores segment is poised to expand at 6% CAGR over the study duration, due to the availability of large variety of drugs, and increasing preference for online shopping among customers.
 

The geographical analysis of worldwide aquaculture healthcare industry extends to North America, Middle East & Africa, Asia Pacific, Europe, and Latin America. Latin America market was valued at USD 110 million in 2019 and is reckoned to grow with 6% CAGR over 2021-2026. This can be credited to the fact that the seas of Latin America and Caribbean Sea are a resource for thousands of families and a source of healthy food.
 

Prominent players influencing the industry trends are Zoetis Inc., Zeal Aqua Ltd., Virbac, Vetoquinol S.A., Merck KGaA, Elanco Animal Health Incorporated, DuPont de Nemours Inc., Ceva Santé Animale, Benchmark Holdings plc, and Archer-Daniels-Midland Company.